Skip to main content

Table 3 Univariable analysis to identify factors associated to malaria chemoprophylaxis recommendation among individuals attended at the Instituto de Infectologia Emílio Ribas, in São Paulo, Brazil, from January 2006 to December 2010

From: Pre-travel malaria chemoprophylaxis counselling in a public travel medicine clinic in São Paulo, Brazil

Variables

Chemoprophylaxis recommendation

OR (CI 95%)

Yes (n;  %)

No (n;  %)

Gender

Male

163 (55.8)

1220 (48.0)

1

Female

129 (44.2)

1324 (52.0)

1.37 (1.07–1.75)

Age group

<Median

165 (56.5)

1253 (49.3)

1

≥Median

127 (43.5)

1291 (50.7)

1.34 (1.05–1.71)

Schooling (years; 90.3%)

<8

8 (2.9)

128 (5.6)

1

8–11

40 (14.7)

447 (19.6)

0.70 (0.32–1.53)

≥12

225 (82.4)

1706 (74.8)

0.47 (0.23–0.98)

Any immunosupressive condition

No

286 (97.9)

2483 (97.6)

Yes

6 (2.1)

61 (2.4)

1.17 (0.50–2.73)

HIV infection

No

290 (99.3)

2512 (98.7)

Yes

2 (0.7)

32 (1.3)

1.85 (0.44–7.75)

Diabetes mellitus

No

288 (98.6)

2510 (98.7)

Yes

4 (1.4)

34 (1.3)

0.97 (0.34–2.77)

Depression

No

283 (96.9)

2459 (96.7)

Yes

9 (3.1)

85 (3.3)

1.87 (0.54–2.18)

Travel reason

Study or work

137 (47.2)

1343 (53.3)

Tourism

125 (43.1)

888 (35.3)

0.72 (0.56–0.94)

Multiples or others

28 (9.7)

288 (11.4)

1.05 (0.68–1.61)

Travel destination

Africa

183 (62.9)

511 (20.3)

Asia

30 (10.3)

387 (15.5)

4.62 (3.07–6.95)

Brazil

30 (10.3)

392 (15.6)

4.67 (3.11–7.04)

Latin American endemic countries

11 (3.8)

205 (8.2)

6.67 (3.55–12.53)

Others

37 (12.7)

1017 (40.5)

9.84 (6.81–14.23)

Accomodation type 2512

Hotel or hostel

79 (32.8)

775 (35.2)

Others

162 (67.2)

1428 (64.8)

0.90 (0.68–1.19)

Length of stay (in days)

≤30

154 (54.2)

1063 (45.0)

31–180

104 (36.6)

701 (29.7)

0.98 (0.75–1.27)

>180

26 (9.2)

598 (25.3)

3.33 (2.17–5.11)

  1. CI confidence interval